source
- What’s next for GLP-1 weight loss drugs?What’s next for GLP-1 weight loss drugs? Alex Hogan explores on the new episode of STATus Report. Watch now.STAT · 1mo ago↗ source
- Kardigan extends biotech’s streak of big IPOs with $400M haulIncluding the heart drug developer’s offering, four biotechs in 2026 have raised at least $400 million in IPO proceeds — the most in a single year since 2021, according to BioPharma Dive data.BioPharma Dive · 1mo ago↗ source
- RFK Jr. presents $700 million in mental health funding, but experts say grants aren’t newRFK Jr. presents funding intended to address mental illness and addiction, particularly among homeless people.STAT · 1mo ago↗ source